The term ‘cancer’ describes more than 200 different diseases and every single one needs to be clearly understood and requires, ideally, individual treatment. To do this we need to deepen our understanding the cancer genome. Report: Anja Behringer
Scientists from the German Cancer Research Center in Heidelberg and from the Medical Faculty Mannheim of Heidelberg University treated mice with a combination of a low-dose metronomic chemotherapy and an antibody against Ang-2, a regulatory protein of the blood vessel lining cells. The treated animals had significantly less metastases.
The human immune system is usually very efficient in protecting the body against diseases by eliminating pathogens as well as infected, damaged or otherwise suspicious cells. However, it often fails because tumours have developed efficient strategies that hamper the system’s ability to detect and destroy the cancer cells. Report. Ludger Weß
The world’s first gene cancer therapy study of an innovative oral vaccine is underway at the Surgical Clinic of Heidelberg University Hospital.
PBT uses a high-energy beam of particles to destroy cancer cells by more accurately targeting the affected areas and is particularly suitable for complex childhood cancers. It also increases success rates and reduces side effects, such as deafness, loss of IQ and secondary cancers.
Excising the entire cancer tumour from the stomach prevents relapses. This procedure can now be performed endoscopically. Holger Zorn reports from the Visceral Medicine 2011 Congress in Leipzig.
Uterine fibroids are the most common benign tumours in women. Treatment is only necessary if the fibroids cause pain and bleeding due to their size and position. Minimally-invasive fibroid embolisation is a gentle, efficient and long-lasting treatment for their removal, leaving the uterus intact. The first evaluations of several international long-term studies have indicated a high success rate…